TABLE 4.

Post hoc analyses in the PNDABLE study.

	Model 1		Model 2		Model 3
	OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
PA	0.366 (0.185–0.722	0.004	0.534 (0.290–0.984)	0.044	0.474 (0.265–0.849)	0.012
Aβ42, pg/ml	0.989 (0.982–0.995)	<0.001	0.991 (0.986–0.997)	0.002	0.991 (0.986–0.996)	0.001
T-tau, pg/ml	1.010 (1.004–1.016)	0.002	1.009 (1.003–1.014)	0.002	1.011 (1.006–1.016)	<0.001
P-tau, pg/ml	1.096 (1.037–1.157)	0.001	1.056 (1.008–1.107)	0.022	1.053 (1.009–1.099)	0.018
Aβ42/T-tau	2.163 (1.253–3.733)	0.006	1.951 (1.210–3.144)	0.006	1.841 (1.131–2.994)	0.014
Aβ42/P-tau	1.163 (0.916–1.476)	0.215	1.050 (0.849–1.298)	0.652	1.086 (0.885–1.332)	0.431

OR, odds ratio; 95% CI, 95% confidence interval.

a Model 1: exclude MMSE <28.

b Model 2: exclude diabetes.

c Model 3: exclude coronary heart disease. The bold values are all p ≤ 0.05, statistically significant parameters. Model 1–3 refers to the model of Hoc Analyses.